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Histone H2AX: A Dosage-Dependent Suppressor
of Oncogenic Translocations and Tumors
HR factors in mice causes increased ionizing radiation
(IR) sensitivity, genomic instability, and embryonic le-
thality, while in humans, such mutations have been
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phocyte development, and dramatically increased lym-The Children’s Hospital
phoma predisposition in the context of p53 tumor sup-Department of Genetics
pressor deficiency (reviewed in Bassing et al., 2002b).Harvard Medical School and
Oncogenic translocations, such as those frequently ob-The Center for Blood Research
served in lymphomas, may result from misrepair of bothBoston, Massachusetts 02115
general and programmed DSBs, and their junctions can2 Tufts University School of Veterinary Medicine
provide substantial mechanistic insight into tumor etiol-200 Westboro Road
ogy (reviewed in Mills et al., 2003).North Grafton, Massachusetts 01536
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sembled by V(D)J recombination, the lymphoid-specificBrigham and Woman’s Hospital
process in which V, D, and J gene segments liberatedHarvard Medical School
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into complete V(D)J coding exons (V genes) via NHEJ
(reviewed in Bassing et al., 2002b). Bone marrow pro-
genitor (pro)-B cells and thymic CD4/CD8 (DN)Summary
pro-T cells assemble IgH and TCR V genes, respectively.
Expression of IgH or TCR chains leads to differentiationWe employed gene targeting to study H2AX, a histone
of precursor (pre)-B or CD4/CD8 (DP) T lineage cells invariant phosphorylated in chromatin surrounding DNA
which, respectively, the majority of IgL ( or ) or TCRdouble-strand breaks. Mice deficient for both H2AX
V genes are assembled. Subsequently, expression ofand p53 (H/P/) rapidly developed immature T and
complete (IgH/IgL) Ig or  TCR leads to the generationB lymphomas and solid tumors. Moreover, H2AX
of IgM B lymphocytes and /TCR T lymphocyteshaploinsufficiency caused genomic instability in nor-
that migrate to the spleen and lymph nodes. Followingmal cells and, on a p53-deficient background, early
antigen stimulation, mature B cells can undergo class-onset of various tumors including more mature B lym-
switch recombination (CSR), which replaces the IgHphomas. Most H2AX/p53/ or H2AX/p53/ B lin-
constant region (C) exons (gene) with a downstream CHeage lymphomas harbored chromosome 12 (IgH)/15
gene and results in expression of a different Ig class (e.g.,(c-myc) translocations with hallmarks of either aber-
IgG or IgE). CSR is initiated by activation-induced deami-rant V(D)J or class switch recombination. In contrast,
nase (AID), may involve DSBs, and occurs between large,H2AX/p53/ thymic lymphomas had clonal translo-
highly repetitive switch (S) regions that precede each CHcations that did not involve antigen receptor loci and
gene (reviewed in Manis et al., 2002).which likely occurred during cellular expansion. Thus,
NHEJ-deficient mice show, at most, a modest predis-H2AX helps prevent aberrant repair of both pro-
position to cancer. However, combined deficiency forgrammed and general DNA breakage and, thereby, func-
NHEJ and p53 leads to rapid development of pro-B
tions as a dosage-dependent suppressor of genomic
lymphomas (reviewed in Bassing et al., 2002b). In this
instability and tumors in mice. Notably, H2AX maps to a regard, p53 monitors DSBs in the context of G1 check-
cytogenetic region frequently altered in human cancers, points and signals either arrest to repair DSBs or apo-
possibily implicating similar functions in man. ptosis to eliminate cells with persistent DSBs (Vogelstein
et al., 2000). Thus, NHEJ-/p53-deficient pro-B cell lym-
Introduction phomas are proposed to result from double mutant
pro-B cells generating unresolved RAG-initiated DSBs
DNA double-strand breaks (DSBs) result from exoge- at the IgH joining (JH) locus on chromosome (chr) 12
nous factors, stalled replication forks, or genetically pro- during G1; these cells progress into S phase and repli-
grammed processes such as those that occur in devel- cate the JH DSBs. Ultimately, such replicated DSBs can
oping lymphocytes. Proper DSB repair is essential for be fused to chr 15 sequences downstream of c-myc to
maintenance of genomic stability and tumor suppres- generate both a der(12)t(12;15) chromosomal transloca-
sion. In mammalian cells, DSBs are repaired largely by tion, subsequently denoted C12;15, and a complex
homologous recombination (HR), which is predominant translocation that harbors amplified IgH and c-myc se-
in the S and G2 cell cycle phases, and by nonhomolo- quences, which is termed a complicon (Zhu et al., 2002).
gous end joining (NHEJ), which predominates in G1 (re- Complicons arise from translocations that generate a
viewed in Jackson, 2002). Mutation of genes encoding dicentric 12;15, with subsequent amplification resulting
via a breakage-fusion-bridge (BFB) mechanism (Difilip-
pantonio et al., 2002; Zhu et al., 2002).*Correspondence: alt@enders.tch.harvard.edu
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Certain evidence suggests a role for histone H2AX, quences was “cleanly” deleted via the loxP/Cre method
a mammalian core histone H2A variant, in sensing or (Bassing et al., 2002a). These mice differ from another
processing DSBs. H2AX represents, on average, about H2AX-deficient strain in which a drug-resistance marker
15% of the cellular H2A pool and is randomly incorpo- replaced H2AX (Celeste et al., 2002), but appear similar
rated into nucleosomes (Rogakou et al., 1998). DSBs with respect to published aspects of phenotype includ-
cause rapid H2AX phosphorylation (a form called ing smaller size, reduced lymphocyte numbers, and im-
-H2AX) along flanking megabase chromatin regions paired CSR (data not shown). To determine whether
(Rogakou et al., 1998, 1999). H2AX contains a conserved H2AX-deficiency resulted in increased cancer predispo-
carboxy-terminal SQE motif that is the consensus target sition, we followed cohorts of 26 H2AX	/	, 12 H2AX/	,
of PI3 kinases, including DNA-PKcs, ATM, and ATR. and 21 H2AX/ mice for about 7 months. During this
These kinases appear to phosphorylate H2AX following time, one H2AX/	 mouse developed a tumor (a tera-
IR, replication stress, and replication-associated DSBs toma), whereas three H2AX	/	 mice succumbed to ag-
(Brown and Baltimore, 2003; Burma et al., 2001; Furuta gressive CD4/CD8 thymic lymphomas with an aver-
et al., 2003; Paull et al., 2000; Ward and Chen, 2001), age mortality of 170 days (Supplemental Table S2). A
which may contribute to repair of DSBs at G1, S, or G2 single H2AX	/	 thymic lymphoma analyzed by spectral
checkpoints. H2AX-deficient cells are IR sensitive, have karyotyping (SKY) harbored a clonal C14;16 translocation
increased genomic instability, and show impaired for- (Figure 2D; Supplemental Table S3). As ATM-deficient thy-
mation of IR-induced foci of DNA repair proteins such mic lymphomas arise with a similar latency and routinely
as BRCA1 and 53BP1 (Bassing et al., 2002a; Celeste et exhibit chr 14 (TCR/
 locus) translocations (Liyanage et
al., 2002) that colocalize with -H2AX foci (Paull et al., al., 2000), this finding is consistent with H2AX functioning
2000; Rappold et al., 2001; Schultz et al., 2000). H2AX- in ATM-mediated surveillance of TCR V(D)J recombina-
deficient cells appear impaired for HR (Bassing et al., tion. We conclude that H2AX-deficiency causes only a
2002a; Celeste et al., 2002) but support normal NHEJ- modest predisposition to lymphoma.
dependent V(D)J recombination on extrachromosomal
substrates (Bassing et al., 2002a). In S. cerevisiae, there H2AX/p53/ and H2AX/p53/ Mice Exhibit
is only one form of H2A, and it contains an SQE motif; Dramatic Predisposition to Lymphomas
phosphorylation of this motif is required for efficient and Other Cancers
DSB repair by NHEJ, but not HR (Downs et al., 2000). To test potential cooperation between p53 and H2AX
H2AX-deficient mice are small, and males are sterile in tumor suppression, we bred H2AX/	 mice with
(Celeste et al., 2002). In the latter context, the Spo11- p53/ mice and then bred offspring to generate cohorts
transesterase initiates meiotic DSBs that induce forma- of H2AX/p53/ (H/P/), H2AX/	p53/ (H/	P/),
tion of -H2AX foci (Mahadevaiah et al., 2001). However, H2AX	/	p53/ (H	/	P/), H2AX/p53/ (H/P/),
male sterility is thought to occur because Spo11-inde- H2AX/	p53/ (H/	P/), and H2AX	/	p53/ (H	/	P/)
pendent -H2AX foci, which cover the X-Y synaptic mice. All genotypes were born near expected Mendelian
body, are required for meiotic sex chromosome pairing
frequencies (Figure 1A), indicating p53 deficiency did
and inactivation (Celeste et al., 2002; Fernandez-Cape-
not affect early viability of H2AX-deficient mice. In addi-
tillo et al., 2003; Mahadevaiah et al., 2001). In wild-type
tion, all genotypes exhibited grossly normal lymphocytemice, RAG-dependent -H2AX foci occur in the vicinity
development (Supplemental Figure S1), consistent withof the TCR locus during V(D)J recombination (Chen
lack of a major impairment in V(D)J recombination. Inet al., 2000). However, although H2AX-deficient mice
this context, most DJH junctions were normal in H	/	P/exhibit reduced lymphocyte numbers (Celeste et al.,
splenocytes, although some contained large deletions2002), there has been no direct evidence linking H2AX
reminiscent of those found in NHEJ-deficient lympho-to V(D)J recombination. Foci of -H2AX also form at the
cytes and occasionally observed in normal B cells (Sup-IgH locus during CSR in activated B cells (Petersen et
plemental Table S4; Nottenburg et al., 1987). We fol-al., 2001), and CSR is impaired in H2AX-deficient mice
lowed cohorts of 21 H/P/, 29 H/	P/, 17 H	/	P/,(Celeste et al., 2002; Petersen et al., 2001). Conceivably,
and 23 H	/	P/ mice for 21 weeks. None of the H	/	P/localization of -H2AX foci to Spo11- and RAG1/2-initi-
mice developed cancer by 21 weeks (Figure 1B). Olderated DSBs or to putative AID-initiated DSBs during CSR
p53-deficient mice develop thymic lymphomas and, lessmay function to suppress aberrant recombination by acti-
frequently, other tumors with an average survival of 4–6vating efficient damage responses or repair processes.
months, depending on the genetic background (Done-Given that H2AX suppresses genomic instability in
hower et al., 1992; Harvey et al., 1993; Jacks et al., 1994).murine cells, it is notable that human H2AX (H2AFX)
In this regard, 5 of 21 cohort H/P/ mice succumbedmaps to a cytogenetic region (11q23) that is altered in
to thymic lymphoma and one to a sarcoma by 21 weeksa large number of human cancers (see Supplemental
(Figure 1B, Table 1).Table S1 online at http://www.cell.com/cgi/content/full/
H	/	P/ mice had significantly shorter lifespans than114/3/359/DC1). Therefore, we sought to determine
other genotypes, becoming moribund with lymphomaswhether H2AX functions as a tumor suppressor in mice.
as early as 6 weeks, with 50% mortality by 10 weeks,
and the majority succumbing to lymphoma by 13 weeksResults
(Figure 1B, Table 1). Of 17 cohort H	/	P/ mice, 12
developed aggressive thymic lymphomas, most ofH2AX-Deficient Mice Exhibit a Modest
which were at the DP or SP stage (Table 1; SupplementalPredisposition to T Cell Lymphomas
Table S3; data not shown). Three cohort H	/	P/ miceWe generated H2AX-deficient (H2AX	/	) mice from mu-
tant ES cells in which one copy of H2AX coding se- (numbers 590, 698, and 888) succumbed to widely dis-
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Figure 1. Effects of p53 Deficiency on Sur-
vival of H	/	 and H/	 Mice
(A) p53 deficiency does not affect early viabil-
ity of H2AX-deficient mice. Shown is the ex-
pected and actual number of relevant off-
spring from H/	p53/ crosses.
(B) Kapplan-Meier curve representing the
percent survival of H/P/ (n  9), H/P/
(n  21), H/	P/ (n  29), and H	/	P/ (n 
17) cohort mice versus age in days.
seminated B220/IgM B lineage lymphomas (Table 1; mice developed teratomas or lymphomas very early,
with over 50% mortality by 17 weeks (Table 1; FigureSupplemental Table S5), a malignancy not common in
p53-deficient mice. In addition, an H	/	P/ mouse too 1B; Supplemental Figure S3). Three of 29 H/	P/ co-
hort mice developed B lineage lymphomas, includingyoung to be included on the cohort also developed a
B220/IgM B lineage lymphoma (Supplemental Tables an Ig/IgL pre-B cell lymphoma, an IgM B lineage
lymphoma, and an IgG1/IgL mature B cell lymphoma;S2 and S5). Several H	/	P/ cohort mice developed
multiple cancers, including a thymic lymphoma and a seven others developed thymic lymphomas (Table 1).
Three slightly older H/	P/ mice also developed Bpro-B cell lymphoma in #698; a thymic lymphoma, a
sarcoma, and a colon adenocarcinoma in #618; an ap- lineage lymphomas (Supplemental Tables S2 and S5).
In addition, four H/	P/ cohort mice developed sarco-parent (see below) pro-B cell lymphoma and a sarcoma
in #888; and a thymic lymphoma and a sarcoma in #162 mas, including one with lung metastases, while three
others developed teratomas (Table 1; Supplemental Fig-(Table 1; Supplemental Figure S2). Therefore, H2AX-
deficiency dramatically accelerates onset of lymphomas ure S3). SKY analysis of two H/	P/ teratomas re-
vealed dramatic aneuploidy, with one containing fourand other cancers on a p53-deficient background.
H/	P/ mice also had shorter lifespans and in- distinct chromosomal translocations potentially impli-
cating reduced H2AX levels (Supplemental Table S6).creased cancer incidence compared to H/P/ mice
(Figure 1B). Notably, a significant percentage of H/	P/ However, as male germ cell tumors occasionally arise
Table 1. Tumors that Developed in Cohort Mice
H	/	P/ H/P/ H/	P/ H	/	P/
Number of mice 23 21 29 17
B lineage lymphoma 0 0 3 (89) 3 (52)
Thymic lymphoma 0 5 (121) 7 (122) 12 (79)
Teratoma 0 0 3 (50) 0
Sarcoma 0 1 (77) 4 (106) 3 (61)
Adenocarcinoma 0 0 0 1 (81)
Cause of death unknown 0 3 (129) 2 (19) 3 (61)
Shown is the number of cohort mice that succumbed to each tumor type. The numbers shown in parentheses indicate the average day at
which mice were moribund and analyzed.
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in p53-deficient mice (Supplemental Table S2), analyses amplification in both tumors (Figures 4B and 4C). Analy-
ses of cloned, amplified 12;15 breakpoints from tumorsof larger numbers of H/	P/ and H/P/ teratomas
will be needed to evaluate relative contributions of H2AX 590 and 698 revealed fusion of JH locus sequences,
consistent with involvement of RAG-initiated DSBs, tohaploinsufficiency versus p53 deficiency. Overall, we con-
clude that the H2AX/	 genotype substantially accelerates regions 320 (590) and 160 (698) kb downstream of c-
myc (Figures 5A and 5B). These translocations occurredtumorigenesis in a p53-deficient background, a conclusion
further substantiated by detailed analyses of H/	P/ lym- in an orientation that would generate a dicentric 12;15
chromosome and that would promote c-myc amplifica-phomas (see below) and confirmed by an independent
study (Celeste et al., 2003 [this issue of Cell]). tion via a BFB mechanism (Zhu et al., 2002). The above
features of H	/	P/ pro-B lymphoma complicons are
shared with those of NHEJ-/p53-deficient pro-B cellH/P/ and H/P/ Thymic Lymphomas Contain
lymphomas and imply a similar overall mechanism ofComplex Translocations
origin (see Discussion). One difference, however, wasSKY of early passage cells from seven H	/	P/ and two
that complicon junctions from H	/	P/ pro-B cell lym-H/	P/ thymic lymphomas revealed striking chromo-
phomas lacked short sequence homologies and con-somal abnormalities in six H	/	P/ and one H/	P/
tained nucleotide additions (Figure 5B), indicating thattumors, most notably translocations often involving sev-
they were catalyzed by classical NHEJ as opposed toeral chromosomes (Figures 2A–2C; Supplemental Table
a microhomology-based end-joining pathway.S3). T cell lymphomas in p53/mice have been reported
SKY and FISH revealed that H	/	P/ B lineage lym-to generally lack chromosomal translocations (Liao et
phoma 888 had a C12;15;3 complicon containing ampli-al., 1998), although extensive cytogenetics have not
fied IgH and c-myc sequences, as well as a normal chrbeen reported. Thus, we conducted SKY on early pas-
12, but that it lacked the clonal C12;15 observed in thesage cells from two H/P/ T cell lymphomas. In con-
590 and 698 H	/	P/pro-B cell tumors and in RAG-trast to H	/	P/ tumors, both H/P/T cell lymphomas
sufficient, NHEJ-/p53-deficient pro-B cell tumors (Fig-lacked clonal translocations, although they did exhibit
ures 3A and 3B; Supplemental Table S5; Difilippantonioaneuploidy or a few nonclonal translocations (Supple-
et al., 2002; Zhu et al., 2002). Southern blotting revealedmental Table S3; Supplemental Figure S4). Furthermore,
two nonamplified JH alleles and confirmed amplificationSKY showed that two additional p53/ thymic lympho-
of the 3IgH RR and of c-myc, in agreement with FISHmas from a parallel cohort also lacked clonal transloca-
results (Figures 4A–4C). Furthermore, assays with antions (S. Rooney and F.W.A., unpublished data). We con-
internal switch  (S) probe revealed several nongerm-clude that H	/	P/ and a subset of H/	P/ thymic
line bands, including one with dramatic amplificationlymphomas are distinct from those of older p53-defi-
(Figure 4D). This finding suggests that the amplifiedcient mice, not only in time of onset, but also in the
12;15 breakpoint involved S rather than JH sequences,frequent occurrence of dramatic genomic instability fea-
an interpretation confirmed by preliminary nucleotideturing complex chromosomal translocations.
sequence analyses (data not shown). Consistent with aDespite localization of RAG-dependent -H2AX foci
more advanced developmental stage, this tumor had ato the TCR locus during V(D)J recombination, we found
clonal J rearrangement (Figure 4E). In this context, theonly one translocation, which was nonclonal, involving
S-involved translocation event may have occurred onchr 14 in the seven analyzed H	/	P/ thymic lympho-
the productive IgH allele separating the VHDJH re-mas (Supplemental Table S3). In addition, none of the
arrangement from C and resulting in the loss of cell-H	/	P/ tumors harbored clonal translocations involv-
surface IgM expression.ing chr 6 or 13, which contain, respectively, the TCR
and TCR loci. However, nearly all H	/	P/ tumors are
CD4/CD8 or CD4/CD8 and also contain TCR gene
H/P/ B Lymphomas Represent More Advancedrearrangements (Supplemental Table S3; data not
Stages of B Cell Developmentshown). Therefore, it is likely that the complex transloca-
All three of the cohort H/	P/ B lineage tumors hadtions arise in association with TCR-triggered rapid cel-
characteristics of cells beyond the pro-B cell stage.lular proliferation during DN to DP thymocyte expansion,
H/	P/ tumor 855 was an Ig/IgL pre-B cell lym-rather than via aberrant V(D)J recombination.
phoma with a complex, clonal C15;12;16 translocation
that contained amplified IgH and c-myc sequences butH/P/ B Cell Lymphomas Contain IgH Locus
which lacked a clonal C12;15 translocation (Figures 3D,Translocations and Complicons with Amplified c-myc
4B, and 4C; Supplemental Table S5). Southern blottingBased on SKY and fluoresence in situ hybridization
revealed two nonamplified, rearranged JH alleles and(FISH), H	/	P/ pro-B cell lymphomas 590 and 698, like
two rearranged S regions, one of which was amplifiedthe vast majority of NHEJ-/p53-deficient pro-B cell
(Figures 4A and 4D). Nucleotide sequencing of the ampli-lymphomas, had clonal, nonreciprocal C12;15 trans-
fied 855 junction revealed that S was rearranged pre-locations, normal chr 12s, and, respectively, clonal
cisely into an unmapped sequence (GA_x6K02T01LGS)C15;12;15 and C15;12;16 complicons (Figure 3C; Sup-
on the Celera database (Figure 5B). Overall, these dataplemental Table S5). Southern blotting with JH probes
indicate the 855 H/	P/ pre-B cell lymphoma containsrevealed three nongermline JH alleles, of which one was
an amplified 12;15 breakpoint involving S sequencesamplified, in both 590 and 698 cells (Figure 4A). Addi-
and that, as in H	/	P/ B cell lymphoma 888, the ampli-tional assays with an IgH 3 regulatory region (IgH3RR)
fied 12;15 translocation involving Swas not associatedprobe and a c-myc probe revealed significant amplifica-
tion of the entire 200 kb CH region and confirmed c-myc with a clonal C12;15. H/	P/ tumor 464 was an IgM
Suppression of Translocations and Cancer by H2AX
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Figure 2. H	/	P/, H/	P/, and H	/	 Thymic Lymphomas Harbor Clonal, Complex Translocations
(A–D) SKY images of a metaphase from H/	P/ thymic lymphoma 609 with C9;16;13, C12;9, C2;1, and C1;2 translocations (A) and images
of representative translocations C11;10;1 (left) and C11;5;1 (right) from H	/	P/ thymic lymphoma 634 (B), C10;11;18 (left) and C11;10;1 (right)
from H	/	P/ thymic lymphoma 603 (C), and the C12;15 (left) and C14;15 (right) translocations of H	/	 thymic lymphoma 455 (D). SKY images
are on the left, DAPI images in the middle, and computer-classified colors on the right (B–D).
B lineage tumor with a clonal, nonreciprocal C12;15 JH sequences (Figure 4A) and deletions of IgH se-
quences on both chromosomes that extended from Stranslocation and a clonal C12;2 translocation, neither
of which harbored obviously amplified IgH or c-myc to, respectively, a region between C
 and S3 and a
region between S1 and the 3 IgHRR (Figure 5A; datasequences (Figures 3E, 4B, and 4C; Supplemental Table
S5). This tumor lacked a normal chr 12. Southern blotting not shown). In addition, this tumor had two clonal J
rearrangements (Figure 4E). FISH with 3IgH RR orrevealed tumor 464 had two rearranged, nonamplified
Cell
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Figure 3. H	/	P/ and H/	P/ B Lympho-
mas Harbor Chr 12;15 Translocations with
Coamplified IgH and c-myc or IgH Fused with
c-myc Exon 1
(A–E) FISH analysis with chromosome paints
and locus specific probes of H	/	P/ B cell
lymphomas 888 (A and B) and 590 (C) and
H/	P/ B cell lymphomas 855 (D) and
464 (E).
(F) SKY analysis showing the clonal C10;12
translocation, normal chr 16, and abnormally
large chr 16 of H/	P/ mature B cell lym-
phoma 690. The SKY image is on the left,
DAPI image in the middle, and computer clas-
sified colors on the right.
c-myc probes demonstrated that that downstream IgH H/	P/ mice was an IgG1/IgL mature B cell lym-
phoma. SKY of 690 cells revealed a clonal C10;12 trans-locus sequences were located at the C12;15 and C12;2
translocation junctions and that c-myc exons 2 and 3 location and an aberrantly large chr 16 in every meta-
phase (Figure 3F; Supplemental Table S5). Southernwere located at the C12;15 junction, with potential dupli-
cation of both IgH and c-myc sequences (Figure 3E; data blotting revealed two nongermline JH alleles, neither of
which was amplified (Figure 4A). In addition, Southernnot shown). We cloned and sequenced the C12;15 translo-
cation junction and confirmed that it involved IgH se- and FISH analyses revealed no amplification of the IgH
region or c-myc (Figures 4B and 4C; data not shown).quences between C
 and S3 fused into c-myc exon 1 in
an orientation that would form a standard C12;15 translo- We conclude that all currently characterized H/	P/
B lineage tumors are distinct from those observed in thecation reminiscent of those found in Burkitt’s lymphomas
(Figures 5A and 5B). context of NHEJ/p53 deficiency. They represent more
mature stages of B cell development and also involveThe third B lineage tumor (690) that developed in
Suppression of Translocations and Cancer by H2AX
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Figure 4. H	/	P/ and H/	P/ B Lympho-
mas Harbor Translocations Involving IgH and
c-myc Sequences
(A–E) Southern blot analysis of tumor and nor-
mal kidney DNA with a JH probe (A), a 3IgHRR
probe (B), a c-myc probe (C), a S probe (D),
and a J probe (E). The LR8 control probe
was used as a control for loading (B and C)
to indicate the amplification of CH and c-myc
sequences. All DNAs were digested with
EcoRI unless otherwise indicated. The third
c-myc hybridizing band in tumor 464 (C) rep-
resents a subclonal C15;9 translocation.
translocations into chr 12 regions well downstream of H2AX/, H2AX/	, and H2AX	/	 thymocytes and found
that H2AX/	 thymocytes express approximately half thethe JH region.
level of H2AX protein as H2AX/ thymocytes (Figure
6B). To evaluate whether H2AX haploinsufficiency re-H2AX Haploinsufficiency Predisposes to Cancer
in a p53-Deficient Background sults in genomic instability in normal lymphocytes, we
examined the cytogenetic consequences of monoallelicClassical tumor suppressor genes lead to cancer follow-
ing loss of heterozygosity (LOH) and inactivation of both H2AX expression by DAPI analyses of stimulated
H2AX/, H2AX/	, and H2AX	/	 splenic T cells. Approxi-allelic copies (Knudson, 1971). However, inactivation of
just one copy of certain genes (haploinsufficiency) also mately half (52%  7%) of the H2AX	/	 T cells exhibited
chromosomal abnormalities (Figure 6C), including chro-may predispose to cancer (Fodde and Smits, 2002). To
distinguish these possibilities with respect to H/	P/ mosomal gaps, fusions, fragments, and detached cen-
tromeres, while only about 10% (11% 3%) of H2AX/tumors, we first examined the H2AX locus in H/	P/
B cell lymphomas 464, 855, and 690. Southern blotting cells contained chromosome abnormalities (Figure 6C)
(H2AX/ versus H2AX	/	, p 0.001). However, approxi-with a probe that hybridizes 3 of the H2AX gene and
distinguishes the H2AX and H2AX	 alleles revealed all mately one-third (30% 4%) of the H2AX/	 T cells exhib-
ited chromosomal aberrations (Figure 6C) (H2AX/ ver-three H/	P/ lymphomas maintained the wild-type
H2AX allele (data not shown). Furthermore, we used sus H2AX/	, p  0.008), demonstrating that biallelic
expression of H2AX is required for full maintenance ofPCR to isolate and sequence the H2AX gene from
H/	P/ B cell lymphomas 464 and 855 and found no genomic stability in normal proliferating T lymphocytes.
Similar conclusions were reached from analyses of cellsmutations within the coding region (data not shown).
Finally, Western analyses revealed that H2AX was ex- from an independently generated H2AX-deficient mouse
(Celeste et al., 2003).pressed in all three H/	P/ B cell lymphomas, as well
as in several H/	P/ T cell lymphomas (Figure 6A).
We conclude that H2AX haploinsufficiency in a p53- Discussion
deficient background leads both to an increased tumor
incidence and the appearance of novel cancers. The Function of H2AX in DSB Repair
and Tumor Suppression
Deficiency for histone H2AX, a core chromatin compo-H2AX Haploinsufficiency Leads to Increased
Genomic Instability in Normal Lymphocytes nent, leads to a markedly increased predisposition to
various tumors in the context of p53 deficiency. More-To investigate the cellular consequences of H2AX
haploinsufficiency, we analyzed expression of H2AX in over, H	/	P/ and H/	P/ lymphoid tumors routinely
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Figure 5. IgH Locus Translocation Breakpoints of H	/	P/ and H/	P/ B Lineage Lymphomas
(A) Schematic representation of where the 12;15 breakpoints (1–5) of indicated tumors map (arrows) within the IgH locus (chr 12) and c-myc
(chr 15).
(B) Sequences of the cloned breakpoints of the 590 and 698 complicons, an amplified junction from tumor 855, and the C12;15 translocation
of tumor 464. Chr 12 sequences are in green, chr 15 sequences in red, and N nucleotides in black. Unmapped genomic sequences are
indicated in lowercase black letters.
exhibit dramatic genomic instability highlighted by clonal tin, such a density drop may not allow H2AX to effec-
tively perform its requisite functions.translocations that, depending on tumor type, are likely
due to G1 defects, S/G2 defects, or both. These findings H	/	P/ mice die largely of very rapid onset thymic
lymphomas, although pro-B lymphomas and solid tu-are consistent with the notion that phosphorylated H2AX
flanking DSBs has a role in multiple cell cycle phases mors also were observed. H/	P/ mice have a later
onset of thymic lymphomas that, on average, still wasthat could include recruitment or organization of repair
factors (Celeste et al., 2002; Fernandez-Capetillo et al., earlier than that of p53/ mice (Supplemental Table S2).
As one of two H/	P/ lymphomas analyzed harbored2002; Paull et al., 2000; Rogakou et al., 1999). The finding
that H2AX haploinsufficiency also results in increased complex translocations and the other was just aneuploid
(Supplemental Table S2), some H/	P/ thymic lympho-genomic instability and cancer incidence, in the absence
of p53, is particularly intriguing and has both clinical mas may arise due to combined effects of reduced
H2AX plus p53 deficiency, while others arise simply from(see below) and mechanistic implications. Thus, normal
(biallelic) H2AX expression levels are crucial for its func- lack of p53. H/	P/ mice, in part due to reduced inci-
dence of thymic lymphomas, show a relatively broadtions. While there are several possibilities, the H2AX
dosage effect may reflect its structural role in chromatin. spectrum of tumors, including more mature B lineage
lymphomas and frequent sarcomas. Presumably, H	/	P/H2AX represents about 15% of cellular H2A, and there
are two H2A molecules per nucleosome. Thus, H2AX mice also would show a greater predisposition to such
tumors if spared from early T and pro-B cell lymphomasshould be present, on average, in about one of three
nucleosomes, and this density might be expected to via conditional H2AX inactivation. There was, however,
one distinct difference in the tumor spectrum of H/	P/drop in haploinsufficient cells. In the context of chroma-
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from replication and subsequent misrepair of G1 phase
DSBs generated by RAG (Zhu et al., 2002) and were
observed previously only in the context of NHEJ and
p53 deficiency (Difilippantonio et al., 2002; Gladdy et
al., 2003; Zhu et al., 2002). H2AX may suppress RAG-
initiated chromosomal translocations by facilitating
NHEJ access to or otherwise functioning in synapsis of
RAG-liberated ends. H2AX could also suppress RAG-
initiated translocations by participating in G1 check-
points to ensure repair of all DSBs before S phase entry.
In this regard, H2AX was reported to have a G2/M check-
point role in the context of low level DNA damage (Fer-
nandez-Capetillo et al., 2002). In addition, S phase H2AX
functions might contribute to suppression of G1-initi-
ated translocations by eliminating potential recombina-
tion targets for persisting RAG-generated ends. Such
functions might include a putative role downstream of
ATM or ATR, possibly in resolution of stalled replications
forks or in maintenance of fragile-site stability (Casper
et al., 2002; Ward and Chen, 2001).
H2AX-Deficient and Haploinsufficient
Lymphoid Tumors
H	/	P/ thymic lymphomas arise very early and do not,
despite numerous clonal translocations, routinely have
translocations involving chromosomes that harbor TCR
loci. Therefore, H	/	P/ thymic lymphomas may involve
chromosomal abnormalities that arise via aberrant re-
pair of general DSBs in rapidly dividing, developing thy-
mocytes; this might mask lymphomas that could arise
later in development due to TCR translocations. H2AX/
p53 deficiency may lead to S phase abnormalities via
defective BRCA1-mediated repair in the absence of
H2AX and lack of Chk2-mediated apoptosis in the ab-
Figure 6. H2AX Haploinsufficiency Predisposes Cells to Tumori- sence of p53 (Bachelier et al., 2003; Hirao et al., 2002;
genesis Jack et al., 2002; Mak et al., 2000). Another possibility
(A and B) Western analysis of (A) H2AX expression (anti-H2AX) in would involve reduced ability to form 53BP1/MDC1 foci
H/P/, H/	P/, and H	/	P/ lymphomas and (B) serial 2-fold required for complete activation of S phase checkpoints
dilutions of total protein of H/, H/	, and H	/	 thymocytes. Histone
following DSBs (Goldberg et al., 2003; Lou et al., 2003;H4 (anti-H4) levels control for sample loading.
Stewart et al., 2003; Wang et al., 2002; Ward et al.,(C) Graph representing the average percent of H/, H/	, and H	/	
2003). Most H	/	P/ thymic lymphomas have a TCR-T cell metaphases with chromosomal abnormalities obtained from
four independent experiments. negative, DP phenotype. Thus, as normal DP thymo-
cytes require  TCR-mediated selection for survival
(Anderson et al., 1999), H	/	P/ thymic lymphomas may
mice relative to H	/	P/ mice; frequent, early-onset arise from DP cells or earlier stage lymphoma stem cells
germ cell tumors in male H/	P/ mice were not ob- via genetic or epigenetic changes that sustain self-
served in male H	/	P/ mice. In this regard, complete renewal or lack of apoptosis. It is curious that H	/	P/
H2AX-deficiency blocks meiosis and p53-deficiency thymic lymphomas do not arise secondarily to TCR
does not rescue this process (Fernandez-Capetillo et locus translocations, despite the contribution of JH
al., 2003); thus, ablation of germ cell development in rearrangements to H	/	P/ pro-B cell lymphomas. In
male H	/	P/ mice may suppress any potential to gen- fact, translocations involving TCR are infrequent in mu-
erate germ cell tumors that might result from combined rine lymphomas. In this regard, the TCR locus may lack
absence of H2AX and p53. capacity to effectively activate linked oncogenes, as
In mammalian cells, H2AX has been implicated in S opposed to the IgH or TCR loci that have long-range
and G2 repair via HR (Bassing et al., 2002a; Celeste et enhancers (Cogne et al., 1994; Sleckman et al., 1997). In
al., 2002). However, a potential role in G1 and NHEJ was addition, given the larger target cell pool, translocations
suggested by localization of H2AX foci to the TCR occurring during rapid expansion after a productive
locus during V(D)J recombination (Chen et al., 2000). We TCR rearrangement may swamp out potential translo-
now show that H2AX, indeed, is required for fully normal cations involving TCR locus rearrangement. Such sce-
ability to process G1 phase DSBs in the context of V(D)J narios also would explain the absence of T cell lympho-
recombination, based on our finding of H	/	P/ pro-B mas in NHEJ-/p53-deficient mice, as the NHEJ defect
cell lymphomas with both signature C12;15 transloca- does not allow DN T cells to generate TCR chains
tions and related complicons derived from JH transloca- to drive expansion or progression to TCR locus re-
arrangement.tions. Such sets of chromosomal anomalies likely result
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H	/	P/ pro-B cell lymphomas had translocated JH or deletion in a large number of human cancers (Supple-
region sequences with deletions reminiscent of those mental Table S1). Moreover, H2AFX maps within the
found in NHEJ-/p53-deficient pro-B cell lymphomas, de- minimal regions of LOH or deletion that have been de-
spite the majority of DJH joins being normal in H	/	P/ fined in a number of studies involving a wide variety of
lymphocytes. Thus, H2AX-deficiency may allow occa- human cancers (Supplemental Table 1). Such findings
sional JH ends to escape joining in G1 and (in the ab- have led to the proposal that the 11q23 region contains
sence of p53) undergo replication, which could result a human tumor suppressor gene(s) in addition to ATM.
in deletions of JH ends (Zhu et al., 2002). Then, such Thus, our finding that H2AX functions as a tumor sup-
replicated DSBs may be translocated to S phase-gener- pressor in mice clearly identifies H2AFX as a strong
ated lesions associated with H2AX deficiency, for exam- candidate for such an additional tumor suppressor gene
ple, from putative fragile sites downstream of c-myc, within the 11q23 region. Analysis of H2AFX sequence
to generate C12;15 (marker) and dicentric (complicon) in a panel of breast cancers revealed an intact H2AFX
12;15 chromosomal junctions. NHEJ-/p53-deficient gene (Monteiro et al., 2003). However, our mouse studies
lymphomas are clonal, consistent with additional muta- show that haploinsufficient H2AX expression dramati-
tion(s) being required for transformation. In this context, cally predisposes to genomic instability and, in the con-
H2AX maps to a region of chr 9 that, by comparative text of p53 deficiency, cancer. As many human lympho-
genomic hybridization, appears frequently deleted in mas and solid tumors contain deletions of 11q23 on a
NHEJ-/p53-deficient pro-B cell lymphomas (Zhu et al., single allele (Supplemental Table S1), loss of a single
2002; Celera database). Conceivably, reduced H2AX lev- copy of H2AFX might play a role in unleashing genetic
els also might contribute to translocation of RAG-initi- instability in humans. For example, H2AFX lies approxi-
ated DSBs in NHEJ-/p53 pro-B cells by facilitating gen- mately 0.6 Mb telomeric of the MLL gene; thus, the
eration of S phase acceptor ends for replicated RAG- 0.6–0.7 Mb deletions that often extend 3 of MLL in
initiated DSBs. Finally, a microhomology-based end- human leukemias with 11q23 translocations involving
joining pathway catalyzed complicon junctions in MLL (Cherif et al., 1994) theoretically could contribute
NHEJ-/p53-deficient pro-B cell lymphomas (Zhu et al., to tumorigenesis through loss of a single copy of H2AFX.
2002). In contrast, translocation junctions in H	/	P/ Moreover, deletions that generate LOH of ATM (which
pro-B cell lymphomas appeared to be catalyzed by classi- regulates p53) in tumors such as mantle cell lymphoma
cal NHEJ. Recent studies have shown that telomere fu- and B cell chronic lymphocytic lymphoma (Schaffner et
sions also can be catalyzed by NHEJ (Smogorzewska al., 1999; Stilgenbauer et al., 1999), may have more se-
et al., 2002). Thus, chromosome translocations can be vere genomic consequences if a single copy of H2AFX
catalyzed by HR (Bosco and Haber, 1998), microhomol- is also inactivated. Clearly, it will be important to exam-
ogy-based end-joining (Zhu et al., 2002), and classical ine the status of both copies of H2AFX in human cancers
NHEJ. exhibiting 11q23 alterations, especially those with marked
No breakpoints associated with defective CSR were genetic instability or recurrent translocations.
found in a large number of NHEJ-/p53-deficient pro-B
cell lymphomas (Difilippantonio et al., 200; Zhu et
Experimental Procedures
al., 2002). However, unlike NHEJ-/p53-deficient mice,
H2AX-/p53-deficient mice generate more mature B-lin- Generation of Mice
eage cells that might have potential to acquire genomic H2AX/	 ES cells (Bassing et al., 2002a) were used to generate 129Sv
H2AX	/	 and H2AX/	 mice. 129Sv H2AX/	 and 129Sv/C57BL/6instability due to impaired IgH CSR. Our analyses of
p53/ mice (Donehower et al., 1992) were bred to generateH	/	P/ and H/	P/ B lineage lymphomas support
H/	P/ mice, which were interbred to generate cohort mice.this notion. Thus, H	/	P/ lymphoma 888 and H/	P/
lymphoma 464 have Ig rearrangements and 12;15 chro-
Characterization of Tumorsmosomal translocations in which apparent chr 12
Lymphomas were characterized by flow cytometry using anti-CD4,breakpoints are well downstream of JH, with one (888),
CD8, CD3, B220, IgM, CD43, Ig, Ig, IgG1 (Pharmingen), and anti-which harbored a 12;15 complicon, having an amplified
IgM (Southern Biotech) antibodies. Solid tumors were characterizedS junction and the other (464), which had a C12;15
via H & E staining. B cell lymphoma cultures were grown as de-
translocation, having a junction downstream of S and scribed (Zhu et al., 2002) or with LPS (Pharmingen) instead of IL7.
C
 into c-myc exon 1. In addition, H/	P/ pre-B cell Metaphase preparation, chromosome painting, SKY, and FISH anal-
lymphoma 855, which had a 12;15 complicon, also har- yses were conducted as described (Zhu et al., 2002). The 3IgH RR
FISH probe was a BAC (199M11) comprised of sequence that extendsbored an amplified S junction. Notably, both H	/	P/
from C through the 3IgH RR (Research Genetics). The JH probe istumor 888 and H/	P/ tumor 855, despite having a
a HindIII/EcoRI genomic fragment containing JH4. The S probe is a12;15 complicon, lacked the companion C12;15 “signa-
HindIII S genomic fragment. The 3IgHRR Southern probe is a 700ture” translocation of replicated DSBs, potentially sug-
bp BamHI fragment just 3 of C.
gesting that the putative initiating lesions in S might
have occurred in S phase. Overall, these findings sug-
Cloning and Sequencing of Translocation Junctionsgest that conditional inactivation of H2AX in mature B
Complicon junctions, DJH, and VHDJH rearrangements were clonedcells may provide the basis for a model of mature B cell by PCR and sequenced as described (Zhu et al., 2002). The 464
lymphomas that arise in association with aberrant CSR. and 590 C12;15 junctions were cloned using, respectively, the
lambda DASH II vector and the lambda ZAP II vector (Stratagene).
Potential Relevance of H2AX Deficiency
or Haploinsufficiency to Human Cancer Western Analyses
Human H2AX (H2AFX) maps 11 Mb telomeric of ATM Tumor cells and normal thymocytes were lysed in Laemmli buffer
and blotting conducted as described (Bassing et al., 2002a).on chromosome 11 at 11q23, a region that exhibits LOH
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Genomic Instability Assays and Nussenzweig, A. (2000). Response to RAG-mediated VDJ cleav-
age by NBS1 and -H2AX. Science 290, 1962–1965.Splenocytes were stimulated with ConA and IL2 for 48 hr (Sleckman
et al., 1997) and metaphases prepared and analyzed as described Cherif, D., Bernard, O., Paulien, S., James, M.R., Le Paslier, D., and
(Bassing et al., 2002a). Assays were performed five times with H/, Berger, R. (1994). Hunting 11q23 deletions with fluorescence in situ
H/	, and H	/	 thymocytes in either wild-type (three times) or p53/ hyridization (FISH). Leukemia 8, 578–586.
(two times) backgrounds. One experiment (p53/) was disregarded
Cogne, M., Lansford, R., Bottaro, A., Zhang, J., Gorman, J., Young,
as 32% of metaphases from putative wild-type cells contained ab-
F., Cheng, H.L., and Alt, F.W. (1994). A class switch control region
normalities, including those only seen in H/	 and H	/	 thymocytes
at the 3 end of the immunoglobulin heavy chain locus. Cell 77,
in the other four experiments, suggesting a potential sample error.
737–747.
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